Table 2 Association between 2 and 5 cm tumor growth patterns and clinicopathological features
From: Prognostic analysis of 2–5 cm diameter gastric stromal tumors with exogenous or endogenous growth
Characteristics | Exogenous (n = 193) | Endogenous (n = 83) | p-value |
|---|---|---|---|
Age (%) | 0.002 | ||
≤ 65 | 147 (76.1) | 49 (75.9) | |
> 65 | 46 (23.9) | 34 (24.1) | |
Gender (%) | 0.412 | ||
Female | 84 (43.5) | 52 (62.6) | |
Male | 109(56.5) | 31 (37.4) | |
GI bleeding (%) | 0.082 | ||
No | 143 (78.8) | 61 (73.5) | |
Yes | 50 (21.2) | 18 (26.5) | |
Tumor site (%) | 0.052 | ||
Small bend | 72 (37.3) | 44 (53.0) | |
Large bend | 73 (37.8) | 23 (27.8) | |
Fundus | 48 (24.9) | 16 (19.2) | |
Adjuvant imatinib (%) | 121 (46.2) | 62 (23.7) | 0.307 |
Mitotic index (%) | 0.660 | ||
≤ 5/HPF | 192 (70.1) | 51 (63.0) | |
> 5/HPF | 82 (29.9) | 30 (37.0) | |
NIH risk grade (%) | 0.248 | ||
Extremely low or low | 157 (81.3) | 64 (77.1) | |
Moderate or high | 36 (18.7) | 19 (22.9) | |
CD117 (%) | 0.071 | ||
( −) or ( +) | 55 (28.5) | 18 (21.7) | |
(+ +) or (+ + +) | 138 (71.7) | 65 (78.3) | |
CD34 (%) | 0.286 | ||
( −) or ( +) | 48 (24.9) | 10 (12.1) | |
(+ +) or (+ + +) | 138 (71.5) | 73(87.9) | |
Ki-67 index (%) | 0.372 | ||
< 5% | 155 (80.3) | 64 (77.1) | |
≥ 5% | 38 (19.7) | 19 (22.9) | |
HB (X̄) | 130 | 121 | 0.005 |
ALB (X̄) | 40.3 | 39.7 | 0.078 |
Resection style (%) | 0.200 | ||
Mesenchymal resection | 179 (64.9%) | 70 (25.4%) | |
Distal gastrectomy | 6 (2.2%) | 7 (2.5%) | |
Proximal gastrectomy | 6 (2.2%) | 5 (1.8%) | |
Total gastrectomy | 1 (0.4%) | 1 (0.4%) | |
Basic disease (%) | 87 (31.5%) | 43 (15.6%) | 0.370 |
Surgical history (%) | 37 (13.4%) | 19 (6.9%) | 0.588 |